MannKind Corp (NASDAQ:MNKD)
| 4.55 Delayed Data As of May 26 |  -0.005 / -0.11%Today’s Change | 2.91 Today|||52-Week Range 5.73 | -13.76% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $1.2B |
Company Description
MannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and orphan lung diseases. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Contact Information
MannKind Corp. 1 Casper Street Danbury Connecticut 06810 |
Employees
Shareholders
| Individual stakeholders | 5.09% |
| Other institutional | 28.75% |
| Mutual fund holders | 24.03% |
Top Executives
| Michael E. Castagna | Chief Executive Officer & Director |
| Lauren M. Sabella | Chief Operating Officer & Executive Vice President |
| Steven B. Binder | Chief Financial Officer |
| Joseph Kocinsky | Chief Technology Officer |
| Kevin Kaiserman | Vice President-Medical Affairs & Safety |
